BoneMet Team

Dr. Moeller Andreasen is an Associate Professor at the Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, where she leads the BoneMets research team investigating bone metastases in breast and prostate cancer. Her academic journey is grounded in industry experience from biotech companies specializing in 3D cell culture technology, followed by a PhD in bone physiology. She brings advanced expertise in spatial transcriptomics, histomorphometry/histology, multiplex-immunostainings, and in situ hybridization.

 

Her research focuses on unique diagnostic bone biopsies to uncover how disseminated cancer cells reshape the bone microenvironment, with the aim of identifying novel therapeutic targets. She is a current member of the ECTS Academy of the European Calcified Tissue Society, actively contributing to bone research and mentoring within the European scientific community.

 

In addition to her academic role, Dr. Andreasen coordinates AI and innovation initiatives at the Department of Clinical Pathology, Odense University Hospital (OUH), leading projects that integrates AI-based technologies into clinical diagnostics and pathology workflows.

Funding

News

  • Dagmar Marshalls Fond has awarded a grant to the PhD project “Can we predict who will develop bone metastases from breast cancer?“
  • We’re excited to welcome PhD student Nichole Pedersen and master’s student Mia Winther Nymark to the BoneMets research team. Their contributions will strengthen our ongoing investigations into bone metastases in prostate cancer, and we’re thrilled to have them on board!
  • Regional support boosts prostate cancer research. The project “Exploring the Spatial Dynamics and Methylation Profile of Cancer-Associated Fibroblasts in Metastatic Prostate Cancer” led by Dr. Andreasen has received funding from Region of Southern Denmark’s Fund for Free and Strategic Research as well as the Regional PhD Fund
  • The Neye Foundation supports the project entitled ‘Can we predict which patients will develop bone metastases from breast cancer?
  • Eva og Henry Frænkels Mindefond provides funding for the PhD project “Can we predict who will develop bone metastases from breast cancer?”, helping to strengthen translational cancer research.
  • Fabrikant Einar Willumsens Mindelegat has awarded a grant to the PhD project “Can we predict who will develop bone metastases from breast cancer?”

Projects

Can we predict the risk of bone metastases in breast cancer patients?

Cancer-associated fibroblasts (CAFs) play a crucial role in the spread of cancer within breast tissue. However, CAFs also interact with key bone cells and may contribute to the establishment of bone metastases. This project will investigate how CAFs influence the bone environment and their role in the development of bone metastases. Additionally, the project aims to develop a screening tool for tissue sections that can predict which breast cancer patients are at high risk of developing bone metastases.
melisa2_black and white

Melisa Kalkan Uguz

PhD student

CMA Lab

Molecular Bone Histology Lab

Danish Spatial Imaging Consortium

University of Southern Denmark

Member

Melisa K.
Uguz

Mia V.
Nymark

Nichole
Pedersen

Scroll to Top